Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3) Peptide
EGLN3
Reactivity: Human
Host: Synthetic
BP, BI
-
- Target See all EGLN3 products
- EGLN3 (Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Characteristics
- EGLN3 peptide corresponds to 12 amino acids of EGLN3.
-
-
- Application Notes
- EGLN3 Peptide is used for blocking the activity of EGLN3 antibody . The EGLN3 antibody ships at 0.5 mg/mL and the EGLN3 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- EGLN3 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
You are here:
